X0306 4 2021-10-26 0 0001452965 MINERVA SURGICAL INC UTRS 0001613867 Behbahani Ali 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 1 0 0 0 Common Stock 2021-10-26 4 C 0 281 A 281 D Common Stock 2021-10-26 4 C 0 704 A 985 D Common Stock 2021-10-26 4 C 0 4196 A 5181 D Common Stock 2021-10-26 4 C 0 3306 A 8487 D Series B Preferred Stock 2021-10-26 4 C 0 281 D Common Stock 281 0 D Series C Preferred Stock 2021-10-26 4 C 0 704 D Common Stock 704 0 D Series D Preferred Stock 2021-10-26 4 C 0 4196 D Common Stock 4196 0 D Subordinated Secured Convertible Promissory Note 11.306 2021-10-26 4 C 0 6155.15 D Series D Preferred Stock 544 0 D Subordinated Secured Convertible Promissory Note 11.306 2021-10-26 4 C 0 5920.31 D Series D Preferred Stock 523 0 D Subordinated Secured Convertible Promissory Note 11.306 2021-10-26 4 C 0 5837.08 D Series D Preferred Stock 516 0 D Subordinated Secured Convertible Promissory Note 11.306 2021-10-26 4 C 0 5674.16 D Series D Preferred Stock 501 0 D Subordinated Secured Convertible Promissory Note 11.306 2021-10-26 4 C 0 5436.88 D Series D Preferred Stock 480 0 D Subordinated Secured Convertible Promissory Note 11.306 2021-10-26 4 C 0 8398.26 D Series D Preferred Stock 742 0 D Series D Preferred Stock 2021-10-26 4 C 0 544 A Common Stock 544 544 D Series D Preferred Stock 2021-10-26 4 C 0 523 A Common Stock 523 1067 D Series D Preferred Stock 2021-10-26 4 C 0 516 A Common Stock 516 1583 D Series D Preferred Stock 2021-10-26 4 C 0 501 A Common Stock 501 2084 D Series D Preferred Stock 2021-10-26 4 C 0 480 A Common Stock 480 2564 D Series D Preferred Stock 2021-10-26 4 C 0 742 A Common Stock 742 3306 D Series D Preferred Stock 2021-10-26 4 C 0 3306 D Common Stock 3306 0 D The Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. Represents $6,155.15 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602. Represents $5,920.31 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602. Represents $5,837.08 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602. Represents $5,674.16 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602. Represents $5,436.88 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602. Represents $8,398.26 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602. /s/ Sasha Keough, attorney-in-fact 2021-10-28